Berthil H. C. M. T. Prinsen, Monique G. M

Slides:

Advertisements

Similar presentations

Pathophysiology of renal fluid retention

Advertisements

Erythropoietin should be part of congestive heart failure management

Anemia management in chronic kidney disease

Erythropoietin should be part of congestive heart failure management

Volume 83, Issue 3, Pages (March 2013)

Progression of renal failure and hypertensive nephrosclerosis

Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome Nosratola D.

Burden of chronic kidney disease: North Africa

Pathophysiology of renal fluid retention

Selective versus Total Insulin Resistance: A Pathogenic Paradox

Volume 58, Issue 1, Pages (July 2000)

Metformin and other antidiabetic agents in renal failure patients

George A. Kaysen, Burl R. Don

Volume 66, Pages S13-S17 (September 2004)

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 55, Issue 3, Pages (March 1999)

Volume 71, Issue 11, Pages (June 2007)

The epidemiology of chronic kidney disease

Edmund G. Lowrie Kidney International

Prevention of renal failure: The Malaysian experience

Study of Heart and Renal Protection (SHARP)

Pieter Evenepoel, Björn K. Meijers Kidney International

New insights into lipid metabolism in the nephrotic syndrome

Saulo Klahr, Jeremiah J. Morrissey Kidney International

Volume 68, Pages S4-S10 (August 2005)

Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra

New insights in uremic toxins

Volume 54, Issue 2, Pages (August 1998)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Choong Kim, Nosratola D. Vaziri Kidney International

Volume 53, Issue 4, Pages (April 1998)

Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson Kidney International

Volume 56, Pages S213-S215 (July 1999)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 73, Issue 9, Pages (May 2008)

Mediterranean diets: are they practical in the Western world?

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Phosphate binders on iron basis: A new perspective?

Clinical benefits of slowing the progression of renal failure

Does equal care give equal outcomes?

Volume 69, Issue 1, Pages (January 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Volume 56, Pages S28-S30 (July 1999)

Charles A. Herzog Kidney International

Volume 65, Issue 3, Pages (March 2004)

Volume 69, Issue 10, Pages (May 2006)

Is complement a target for therapy in renal disease?

Volume 75, Issue 7, Pages (April 2009)

Ziad A. Massy Kidney International

Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease Aquiles Jara, Arnold J. Felsenfeld, Jordi.

Volume 64, Issue 4, Pages (October 2003)

Renal vascular disease in the elderly

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

D.J. Askenazi, D.I. Feig, N.M. Graham, S. Hui-Stickle, S.L. Goldstein

Volume 67, Issue 1, Pages (January 2005)

Volume 74, Issue 10, Pages (November 2008)

Lipoprotein abnormalities in diabetic nephropathy

Morphology of the heart and arteries in renal failure

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

Volume 64, Pages S131-S136 (November 2003)

Presentation transcript:

Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms Berthil H.C.M.T. Prinsen, Monique G.M. de Sain-van der Velden, Eelco J.P. de Koning, Hein A. Koomans, Ruud Berger, Ton J. Rabelink Kidney International Volume 63, Pages S121-S124 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.34.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Simplified models concerning different metabolic pathways. Shown are the pathways for triglyceride synthesis in normal subjects (A), and in patients with CRF (B). Abbreviations are: FFA, free fatty acids; hSL, hormone sensitve lipase; TG, triglycerides; LPL, lipoprotein lipase. Kidney International 2003 63, S121-S124DOI: (10.1046/j.1523-1755.63.s84.34.x) Copyright © 2003 International Society of Nephrology Terms and Conditions